Status:
COMPLETED
Effects of a Supervised Progressive Resistance Training With Breast Cancer Patients During Adjuvant Radiotherapy
Lead Sponsor:
German Cancer Research Center
Collaborating Sponsors:
University Hospital Heidelberg
National Center for Tumor Diseases, Heidelberg
Conditions:
Breast Cancer
Cancer-related Fatigue
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this randomized intervention study is to investigate the effects and biological mechanisms of a supervised 12-week progressive resistance training on fatigue and immunological and infla...
Eligibility Criteria
Inclusion
- histologically confirmed primary breast cancer, stage I-III, after lumpectomy or mastectomy, indication for adjuvant radiotherapy
- BMI: 18-40
- ability to understand and follow the study protocol
Exclusion
- contraindication for exercise
- participation in the BEATE trial or another systematic resistance or relaxation training
Key Trial Info
Start Date :
February 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2014
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT01468766
Start Date
February 1 2011
End Date
July 1 2014
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Center for Tumor Diseases
Heidelberg, Germany, 69120